Pluri Inc. (PLUR) Form 10-Q Quarterly Reports
Pluri Inc. (PLUR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PLUR
CIK: 1158780
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 06/30
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kesselman & Kesselman C.P.A.s
Auditor SinceSince 6/30/2021 12:00:00 AM
Lead Engagement PartnerLior Flexer Oshri
Audit LocationHaifa, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-15 | — | EFFECT Filing | 9999999995-26-003262 | View SEC Doc Filr Page |
| S-1 | 2026-10-06 | — | REGISTRATION STATEMENT | 0001213900-26-107182 | View SEC Doc Filr Page |
| S-3 | 2026-09-11 | — | REGISTRATION STATEMENT | 0001213900-26-098906 | View SEC Doc Filr Page |
| S-8 | 2026-09-11 | — | REGISTRATION STATEMENT | 0001213900-26-098900 | View SEC Doc Filr Page |
| S-8 | 2026-09-11 | — | REGISTRATION STATEMENT | 0001213900-26-098899 | View SEC Doc Filr Page |
| 10-K | 2026-09-10 | 2026-06-30 | ANNUAL REPORT | 0001213900-26-098862 | View SEC Doc Filr Page |
| D | 2026-09-04 | — | D Filing | 0001213900-26-097418 | View SEC Doc Filr Page |
| 424B5 | 2026-08-28 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-094704 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-26 | CURRENT REPORT | 0001213900-26-094638 | View SEC Doc Filr Page |
| 424B3 | 2026-08-27 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-094106 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 Filing | 0001213900-26-093070 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 Filing | 0001213900-26-093064 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-12 | CURRENT REPORT | 0001213900-26-090738 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-14 | CURRENT REPORT | 0001213900-26-077960 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-07 | CURRENT REPORT | 0001213900-26-077548 | View SEC Doc Filr Page |
| 3 | 2026-07-07 | 2026-06-19 | 3 Filing | 0001213900-26-075934 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001213900-26-074214 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-01 | — | SCHEDULE 13D/A Filing | 0001213900-26-074213 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-15 | CURRENT REPORT | 0001213900-26-070609 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-28 | CURRENT REPORT | 0001213900-26-063500 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-056586 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-03-31 | 4 Filing | 0001213900-26-051531 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-01 | — | SCHEDULE 13D/A Filing | 0001213900-26-051095 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-06-30 | FORM ARS | 0001213900-26-047072 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-047071 | View SEC Doc Filr Page |